October 17, 2017 – Scenic appoints Stephen Friend and Ton Schumacher to its scientific advisory board
Scenic Biotech BV, a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for rare genetic disorders and other devastating illnesses, appoints Ton Schumacher and Stephen Friend to its scientific advisory board.
About Ton Schumacher: Ton is a Group leader at the Netherlands Cancer Institute and Professor of Immunotechnology at Leiden University. Dr Schumacher is Co-founder of The T-Cell Factory (acquired by Kite Pharma/Gilead), AIMM Therapeutics, and Neon Therapeutics. Ton is a world leader in tumor neoantigens and immuno-oncology.
About Stephen Friend: Stephen is Chairman of Sage Bionetworks, President and co-founder of 4YouandMe, former Director at Apple Inc., Senior VP at Merck & Co, and co-founder of Rosetta Inpharmatics. Dr Friend has held faculty positions at Harvard Medical School, Massachusetts General Hospital, The University of Washington, and Mt Sinai Hospital. Stephen is a world leader in genetics oncology and health informatics.